Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity

Yiyu Dong, Yongxing Gong, Fengshen Kuo, Vladimir Makarov, Ed Reznik, Gouri J. Nanjangud, Omer Aras, Huiyong Zhao, Rui Qu, James A. Fagin, Eric J. Sherman, Bin Xu, Ronald Ghossein, Timothy A. Chan and Ian Ganly

Mol Cancer Ther February 1 2022 (21) (2) 382-394; DOI: 10.1158/1535-7163.MCT-21-0224